JP2005533800A5 - - Google Patents

Download PDF

Info

Publication number
JP2005533800A5
JP2005533800A5 JP2004514806A JP2004514806A JP2005533800A5 JP 2005533800 A5 JP2005533800 A5 JP 2005533800A5 JP 2004514806 A JP2004514806 A JP 2004514806A JP 2004514806 A JP2004514806 A JP 2004514806A JP 2005533800 A5 JP2005533800 A5 JP 2005533800A5
Authority
JP
Japan
Prior art keywords
liver
composition
use according
composition according
regeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004514806A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005533800A (ja
JP5144876B2 (ja
Filing date
Publication date
Priority claimed from DE2002127611 external-priority patent/DE10227611A1/de
Application filed filed Critical
Priority claimed from PCT/EP2003/006509 external-priority patent/WO2004001023A2/de
Publication of JP2005533800A publication Critical patent/JP2005533800A/ja
Publication of JP2005533800A5 publication Critical patent/JP2005533800A5/ja
Application granted granted Critical
Publication of JP5144876B2 publication Critical patent/JP5144876B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004514806A 2002-06-20 2003-06-20 増殖因子を用いて、および生物学的マトリクスあるいは支持構造を用いて細胞を増殖および分化する方法およびデバイス Expired - Lifetime JP5144876B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10227611.0 2002-06-20
DE2002127611 DE10227611A1 (de) 2002-06-20 2002-06-20 Verfahren und Vorrichtung zur Vermehrung und Differenzierung von Zellen in Anwesenheit von Wachstumsfaktoren und einer biologischen Matrix oder Trägerstruktur
DE10234204.0 2002-07-26
DE10234204 2002-07-26
PCT/EP2003/006509 WO2004001023A2 (de) 2002-06-20 2003-06-20 Verfahren und vorrichtung zur vermehrung und differenzierung von zellen in anwesenheit von wachstumsfaktoren und einer biologischen matrix oder trägerstruktur

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010118753A Division JP2010209110A (ja) 2002-06-20 2010-05-24 増殖因子を用いて、および生物学的マトリクスあるいは支持構造を用いて細胞を増殖および分化する方法およびデバイス

Publications (3)

Publication Number Publication Date
JP2005533800A JP2005533800A (ja) 2005-11-10
JP2005533800A5 true JP2005533800A5 (enExample) 2010-01-28
JP5144876B2 JP5144876B2 (ja) 2013-02-13

Family

ID=30001461

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004514806A Expired - Lifetime JP5144876B2 (ja) 2002-06-20 2003-06-20 増殖因子を用いて、および生物学的マトリクスあるいは支持構造を用いて細胞を増殖および分化する方法およびデバイス
JP2010118753A Pending JP2010209110A (ja) 2002-06-20 2010-05-24 増殖因子を用いて、および生物学的マトリクスあるいは支持構造を用いて細胞を増殖および分化する方法およびデバイス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010118753A Pending JP2010209110A (ja) 2002-06-20 2010-05-24 増殖因子を用いて、および生物学的マトリクスあるいは支持構造を用いて細胞を増殖および分化する方法およびデバイス

Country Status (9)

Country Link
US (2) US20060035374A1 (enExample)
EP (1) EP1517988B1 (enExample)
JP (2) JP5144876B2 (enExample)
CN (2) CN1668734A (enExample)
AU (1) AU2003253015A1 (enExample)
CA (1) CA2495395C (enExample)
DK (1) DK1517988T3 (enExample)
ES (1) ES2422881T3 (enExample)
WO (1) WO2004001023A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026480A1 (de) * 2000-05-29 2001-12-13 Augustinus Bader Verfahren zur Herstellung eines empfängerspezifischen Gewebe-Transplantats oder -Implantats
WO2004027064A2 (en) * 2002-09-18 2004-04-01 Centre Hospitalier De L'universite De Montreal (Chum) Ghrh analogues
EP1550715A1 (de) * 2003-12-30 2005-07-06 Bionethos Holding Gmbh Verfahren zur Regenation von Gewebe
PT1699915E (pt) * 2003-12-30 2010-08-31 Augustinus Bader Utilização de eritropoietina para a regeneração de tecido hepático
FR2870739B1 (fr) * 2004-05-26 2008-05-16 Oreal Utilisation du lif en cosmetique et en dermatologie
JP2007023002A (ja) * 2005-07-21 2007-02-01 Univ Of Tsukuba 肝再生促進剤
JP4696247B2 (ja) * 2006-12-11 2011-06-08 国立大学法人 筑波大学 肝線維化抑制剤
JP5098018B2 (ja) * 2007-03-06 2012-12-12 国立大学法人 筑波大学 肝炎治療剤
EP2018835B1 (de) 2007-07-09 2014-03-05 Augustinus Bader Wirkstoff abgebendes Pflaster
EP2192907B1 (en) 2007-08-16 2018-04-18 Remedor Biomed Ltd. Erythropoietin and fibronectin compositions for therapeutic applications
JP5553769B2 (ja) 2007-12-28 2014-07-16 アウグスティヌス・バーダー 皮膚創傷治癒のためのエリスロポエチンの局所適用および製剤
CA2719437A1 (en) * 2008-03-31 2009-10-08 Augustinus Bader Method and composition for the regeneration of tissue with the aid of stem cells or bone-marrow cells
EP2379122B1 (en) * 2008-12-24 2015-06-17 Augustinus Bader Rapid preparation and use of engineered tissue and scaffolds as individual implants
CN103124492A (zh) * 2010-05-28 2013-05-29 加内特生物治疗学股份有限公司 使用具有来源于体外培养和扩增的自我更新集落形成细胞的组分的有生命的和无生命的生物反应装置的组合物和方法
WO2012003960A1 (en) 2010-07-06 2012-01-12 Augustinus Bader Topical application of erythropoietin for the treatment of eye disorders and injuries
WO2012031778A1 (de) 2010-09-12 2012-03-15 Augustinus Bader Verwendung von erythropoietin bei der heilung von wunden oder gewebedefekten ohne narbenbildung
US20130261058A1 (en) * 2010-09-16 2013-10-03 University Of Miami Acceleration of wound healing by growth hormone releasing hormone and its agonists
JP5966129B2 (ja) * 2011-01-31 2016-08-10 オリンパス株式会社 免疫賦活剤
CN104004709B (zh) * 2014-05-05 2016-05-18 曾奕明 用于促进人胚肺成纤维细胞增殖分化的多种生长因子复合物纤维蛋白凝胶释放系统
US10456346B2 (en) 2016-11-10 2019-10-29 Asc Regenity Ltd. Cosmetic formulations for topical applications containing erythropoietin-derived molecules

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US4963489A (en) * 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5073492A (en) * 1987-01-09 1991-12-17 The Johns Hopkins University Synergistic composition for endothelial cell growth
CA2047718A1 (en) * 1989-03-15 1990-09-16 Marston Manthorpe Purified ciliary neurotrophic factor
US5492891A (en) * 1991-09-05 1996-02-20 Novo Nordisk A/S Method for treatment of patients with chronic liver disease
US5427975A (en) * 1993-05-10 1995-06-27 Delco Electronics Corporation Method of micromachining an integrated sensor on the surface of a silicon wafer
EP0726749B1 (en) * 1993-11-03 2004-08-11 Clarion Pharmaceuticals, Inc. Hemostatic patch
US7008634B2 (en) * 1995-03-03 2006-03-07 Massachusetts Institute Of Technology Cell growth substrates with tethered cell growth effector molecules
US6419920B1 (en) * 1995-10-25 2002-07-16 Trans Karyotic Therapies, Inc. Hybrid matrix implants and explants
JPH1067678A (ja) * 1996-06-20 1998-03-10 Chugai Pharmaceut Co Ltd 肝疾患治療用医薬組成物
US5945337A (en) * 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US5919702A (en) * 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
US6274158B1 (en) * 1998-02-04 2001-08-14 Veronica L. Zaharia Czeizler Treatment with recombinant human erythropoietin of bleeding in patients with normal and abnormal hemostasis
WO2000034443A2 (en) * 1998-12-07 2000-06-15 Bartelmez Stephen H Megakaryocyte-induced expansion of hematopoietic stem cells
US6479064B1 (en) * 1999-12-29 2002-11-12 Children's Medical Center Corporation Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
US6319942B1 (en) * 2001-06-06 2001-11-20 Nicholas V. Perricone Topical scar treatments using alkanolamines

Similar Documents

Publication Publication Date Title
JP2005533800A5 (enExample)
CA2380072A1 (en) Nicotine in therapeutic angiogenesis and vasculogenesis
JP2022031772A5 (enExample)
JP2005511635A5 (enExample)
JP2007523178A5 (enExample)
JP2003503454A5 (enExample)
JP2005503183A5 (enExample)
JP2010525073A5 (enExample)
CA2413163A1 (en) 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides
JP2007500209A5 (enExample)
PL3103800T3 (pl) Związki kwasu 1,2,4-oksadiazolobenzoesowego i ich zastosowanie do supresji mutacji nonsensownych i leczenia choroby
JP2010528011A5 (enExample)
JP2010503396A5 (enExample)
JP2004515500A5 (enExample)
JP2007517055A5 (enExample)
JP2008505857A5 (enExample)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2006512324A5 (enExample)
JP2008531742A5 (enExample)
JP2008513510A5 (enExample)
JP2006504787A5 (enExample)
JP2004532213A5 (enExample)
EE05124B1 (et) Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine
JP2007512377A5 (enExample)
JP2002537256A5 (enExample)